Vanguard Group Inc I Bio, Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.23 - $160.0 $190,862 - $133 Million
829,836 Added 7.51%
11,884,917 $2.02 Million
Q2 2022

Aug 12, 2022
BUY
$0.23 - $0.46 $418,579 - $837,158
1,819,910 Added 19.71%
11,055,081 $2.92 Million
Q1 2022

May 13, 2022
SELL
$0.3 - $0.61 $401,600 - $816,588
-1,338,669 Reduced 12.66%
9,235,171 $3.96 Million
Q4 2021

Feb 14, 2022
BUY
$0.55 - $1.04 $34,228 - $64,722
62,233 Added 0.59%
10,573,840 $5.81 Million
Q3 2021

Nov 12, 2021
BUY
$1.06 - $1.52 $65,618 - $94,094
61,904 Added 0.59%
10,511,607 $11.1 Million
Q2 2021

Aug 13, 2021
BUY
$1.22 - $1.65 $12.7 Million - $17.2 Million
10,449,703 New
10,449,703 $15.8 Million

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email